Barriers to Medication Adherence in Behaviorally and Perinatally Infected Youth Living with HIV
- First Online:
- 841 Downloads
The study explored barriers to antiretroviral medication adherence in perinatally and behaviorally HIV infected adolescents and young adults in a cross-sectional, multisite sample. The study included a subset of a convenience sample from a cross-sectional analysis. Participants were youth with HIV ages 12–24 who were prescribed HIV medication and reported missing medication in the past 7 days (n = 484, 28.4 % of protocol sample). The top barriers were similar for perinatally and behaviorally infected youth, but perinatally infected youth reported significantly more barriers. Forgetting, not feeling like taking medication and not wanting to be reminded of HIV infection were the most common barriers reported. Number of barriers was significantly correlated with percent of doses missed, viral load, and psychological distress for perinatally infected youth and with doses missed, psychological distress, and substance use for behaviorally infected youth. Interventions to improve adherence to HIV medications should not only address forgetfulness and choosing not to take medications, but also consider route of infection.
KeywordsAntiretroviral medication adherence Route of infection Barriers to adherence Youth living with HIV Intervention development
- 1.Joint United Nations Programme on HIV/AIDS. Report on the global AIDS epidemic. Mexico City, August: International AIDS Conference; 2008.Google Scholar
- 2.Arnett JJ. Emerging adulthood: the winding road from the late teens through the twenties. New York: Oxford University Press; 2004.Google Scholar
- 6.Foster C, Fidler S. Adolescents with perinatally acquired HIV-1 Infection. Eur Infect Dis. 2011;5(1):10–6.Google Scholar
- 11.Derogatis LR, Spencer PM. The brief symptom inventory (BSI): administration, and procedures manual-I. Baltimore, MD: Clinical Psychometric Research.Google Scholar
- 12.Knight JR, Shrier LA, Bravender TJ, Farrell M, Vander Bilt J, Shafer HJ. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med. 1999;53:591–6.Google Scholar
- 14.Woods PW, Moran LM, Carey CL, Dawson MS. ludicello JE, Gibson S, Grant I, Atkinson JH, the HIV Neurobehavioral Research Center (HNRC) Group. Prospective memory in HIV infection: Is “remembering to remember” a unique predictor of self-reported medication management? Arch Clin Neuropsychol. 2008;23(3):257–70.Google Scholar
- 17.Roux P, Kouanfack C, Cohen J, Marcellin F, Boyer S, Delaporte E, Carrieri P, Laurent C, Spire B, the Stratall ANRS 12110/ESTHER Study Group. Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon content: Promoting the use of medication reminder methods. J AIDS. 2011;57(6S):S40–S43.Google Scholar
- 18.Tanney MR, Naar-King S, MacDonell K. Depression and stigma in high-risk youth living with HIV: a multi-site study. J Pediatr Health Care (in press).Google Scholar
- 21.British HIV Association/Medical Society for the Study of Venereal Diseases (MSSVD). Guidelines on provision of adherence support to individuals receiving antiretroviral therapy. http://www.aidsmap.com/cms1032065. Accessed February 12, 2012; 2002.
- 22.Stone A, Shiffman S. Ecological momentary assessment (EMA) in behavioral medicine. Ann Behav Med. 1994;16(3):199–202.Google Scholar
- 24.Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. October 14, 2011;1–167. http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Accessed February 21, 2012.